Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01576393 · ClinicalTrials.gov registry record · Phase 1

Adolescent Involvement in Parental Substance Abuse Treatment

A Phase 1 study of Substance Abuse, sponsored by Ohio State University.

Completed
Registry status
Phase 1
Development phase
183
Enrollment target
1
Study location

NCT01576393: Completed Phase 1 study of Substance Abuse, sponsored by Ohio State University.

NCT01576393 is a Phase 1 study of Substance Abuse that has completed, run by Ohio State University. The registered enrollment target is 183 participants, below the 5,257-participant average among 58 other Substance Abuse trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01576393, a Phase 1 study of Substance Abuse, has completed, sponsored by Ohio State University.

COMPLETED
Registry status
Phase 1
Development phase
183 participants
Enrollment target
1
Study location

Study Summary

Given the reciprocal nature of parent-child interaction, involvement of the adolescent in their mother's substance abuse treatment plan might be associated with reductions in adult relapse and improvements in child functioning. These findings would support the assertion that focus on family dynamics in substance abuse treatment programs is an effective use of resources and an important target of intervention efforts. One hundred eighty-three substance abusing mothers and their child (n=61 assigned to each condition) will receive treatment as usual (TAU) and be randomly assigned to 1) Ecologically-based family therapy (EBFT) conducted in the home or 2) Ecologically-based family therapy conducted at the treatment center, or 3) an attention control, Women's Health Education (WHE). In order to examine the endurance of treatment effects, this project will assess the parent and child at 3, 6, 12, and 18 months post-baseline. Hypotheses 1. It is expected that 1) mothers and children assigned to home and office based family therapy will show greater reductions in substance use and improvement in individual and family functioning at post-treatment compared to those in the attention control, and 2) those assigned to home-based family therapy will show greater reductions in substance use and improved individual and family functioning at post-treatment compared to those assigned to office-based family therapy. 2. It is expected that 1) those assigned to home or office based family therapy will continue to maintain improvements in substance use, individual and family domains over time (time by treatment interaction) compared to those assigned to the attention control and 2) those assigned to home-based family therapy will continue to maintain improvements in substance use, individual and family domains over time (time by treatment interaction) compared to those assigned to office-based family therapy. 3. It is hypothesized that improved family interaction skills will mediate s

Primary Outcome

Change in frequency of reported substance use

Conditions Studied

Interventions

  • BEHAVIORAL Home-based Family Therapy
  • BEHAVIORAL office-based family therapy
  • BEHAVIORAL WHE

Study Locations (1)

Ohio

  • The Ohio State University - Columbus

Trial Details

FieldValue
Enrollment Target 183 participants
Start Date 2009-08
Est. Completion 2015-04
Phase Phase 1
Ohio State University

552 total trials

What the finished NCT01576393 record still lists

NCT01576393 is an interventional study that assigns participants to a tested intervention. The registered 183 participants enrollment target is mid-sized for trials with a published cap, below the 5,257-participant average among 58 other Substance Abuse trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Substance Abuse appearing as the primary indexed condition, and to 3 interventions - of which Home-based Family Therapy is the first listed.

NCT01576393 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT01576393 about?

NCT01576393 is a clinical study titled "Adolescent Involvement in Parental Substance Abuse Treatment". Given the reciprocal nature of parent-child interaction, involvement of the adolescent in their mother's substance abuse treatment plan might be associated with reductions in adult relapse and improvements in child functioning. These findings would support the assertion that focus on family dynamics...

What is the current status of trial NCT01576393?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 183 participants. The study started on 2009-08. Estimated completion is 2015-04.

What conditions does trial NCT01576393 study?

This clinical trial studies the following conditions: Substance Abuse.

What interventions are being tested in trial NCT01576393?

The interventions under investigation include: Home-based Family Therapy (BEHAVIORAL), office-based family therapy (BEHAVIORAL), WHE (BEHAVIORAL).

Who is sponsoring clinical trial NCT01576393?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01576393 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Abuse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01576393's enrollment target sits among peer trials

183 26th of 58 higher than 33 of 58 other Substance Abuse trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Substance Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03859297 · 183 participants · NA

    Mechanisms of Rumination Change in Adolescent Depression

  • NCT04270591 · 183 participants · Phase 1

    Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer

  • NCT06764615 · 183 participants · Phase 2

    A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

  • NCT06872684 · 183 participants · NA

    Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01576393, the US trial registry maintained by the National Library of Medicine. NCT01576393 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.